[194] 我很感激牛津大学基督圣体学院约翰·沃茨在这个论题上给我的劝告。
[195] 联合国艾滋病规划署，人类免疫缺陷病毒/艾滋病国别估计和数据表，2000年6月；J. T.
Gathii, ‘Construing Intellectual Property Rights and Competition Policy Consistency with Facilitating
Access to Affordable AIDS Drugs to Low-End Consumers’, Florida Law Review 53 (2001), p. 734; A.
Tabor, ‘Recent Developments: AIDS Crisis’, Harvard Journal on Legislation 38 (2001), p. 525。如下
会议报告提出了一个很好的调查：Sarah Joseph, ‘The ‘‘Third Wave’’ of Corporate Human Rights
Accountability: Pharmaceuticals and Human Rights’, Conference, Castan Centre for Human Rights
Law, Monash University, 10–11 Dec. 2001。
[196] The Guardian, 18 May 2004.
[197] 见Joseph, ‘ ‘‘Third Wave’’ of Corporate Human Rights Accountability’, nn. 71, 72。
[198] 比如说Onora O’Neill, Towards Justice and Virtue (Cambridge: Cambridge University Press,
1991), ch. 5 sect. 2。
[199] 出处同上，第131—134页。
[200] 例如 Carl Wellman, Welfare Rights (Totowa, NJ: Rowman and Allanheld, 1982), p. 181。
[201] 关于奥涅尔的主张，见John Tasioulas, ‘The Moral Reality of Human Rights’, in Thomas Pogge
(ed.), Freedom from Poverty as a Human Right: Who Owes What to the Very Poor? (Oxford: Oxford
University Press, 2007)。
